TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
1.670
-0.100 (-5.65%)
Sep 23, 2026, 3:22 PM EDT - Market open
TransCode Therapeutics Employees
TransCode Therapeutics had 12 employees as of December 31, 2025. The number of employees increased by 5 or 71.43% compared to the previous year.
Employees
12
Change (1Y)
5
Growth (1Y)
71.43%
Revenue / Employee
n/a
Profits / Employee
-$3,857,068
Market Cap
28.27M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 12 | 5 | 71.43% | 12 | 0 |
| Dec 31, 2024 | 7 | -3 | -30.00% | 7 | 0 |
| Sep 30, 2024 | 8 | -2 | -20.00% | 8 | 0 |
| Dec 31, 2023 | 10 | -9 | -47.37% | 10 | 0 |
| Dec 31, 2022 | 19 | 10 | 111.11% | 19 | 0 |
| Dec 31, 2021 | 9 | 3 | 50.00% | 8 | 1 |
| Sep 30, 2021 | 7 | 1 | 16.67% | 7 | 0 |
| Jun 30, 2021 | 6 | 0 | - | 2 | 4 |
| Mar 31, 2021 | 6 | 0 | - | 2 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Evaxion | 46 |
| BeyondSpring | 44 |
| NextCure | 40 |
| Quince Therapeutics | 38 |
| Kyntra Bio | 34 |
| ABVC BioPharma | 19 |
| Quantum BioPharma | 17 |
RNAZ News
- 1 day ago - Transcode Therapeutics announces patent advancements in Australia and Japan - TheFly
- 1 day ago - Transcode Therapeutics announces patent advancements in Australia and Japan - TheFly
- 1 day ago - TransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology - PRNewsWire
- 6 days ago - TransCode Therapeutics Transcript: Investor update - Transcripts
- 12 days ago - Transcode Therapeutics CFO Fitzgerald retiring, Tattory named interim CFO - TheFly
- 12 days ago - TransCode Therapeutics Announces Leadership Transition - PRNewsWire
- 23 days ago - Transcode Therapeutics announces publication of article on TTX-MC138 - TheFly
- 23 days ago - TransCode Therapeutics Announces Publication Demonstrating Survival Benefit of TTX-MC138 in Preclinical Model of Breast Cancer Bone Metastasis - PRNewsWire